Glioma extracellular vesicles for precision medicine: prognostic and theragnostic application
| Author | Marei, Hany E. |
| Author | Althani, Asmaa |
| Author | Afifi, Nahla |
| Author | Hasan, Anwarul |
| Author | Caceci, Thomas |
| Author | Cifola, Ingrid |
| Author | Caratelli, Sara |
| Author | Sconocchia, Giuseppe |
| Author | D’Agnano, Igea |
| Author | Cenciarelli, Carlo |
| Available date | 2023-03-29T08:06:11Z |
| Publication Date | 2022-12-01 |
| Publication Name | Discover Oncology |
| Identifier | http://dx.doi.org/10.1007/s12672-022-00514-0 |
| Citation | Marei, H.E., Althani, A., Afifi, N. et al. Glioma extracellular vesicles for precision medicine: prognostic and theragnostic application. Discov Onc 13, 49 (2022). https://doi.org/10.1007/s12672-022-00514-0 |
| Abstract | EV produced by tumour cells carry a diverse population of proteins, lipids, DNA, and RNA molecules throughout the body and appear to play an important role in the overall development of the disease state, according to growing data. Gliomas account for a sizable fraction of all primary brain tumours and the vast majority of brain malignancies. Glioblastoma multiforme (GBM) is a kind of grade IV glioma that has a very dismal prognosis despite advancements in diagnostic methods and therapeutic options. The authors discuss advances in understanding the function of extracellular vesicles (EVs), in overall glioma growth, as well as how recent research is uncovering the utility of EVs in glioma diagnostics, prognostic and therapeutics approaches. |
| Language | en |
| Publisher | Springer |
| Subject | Diagnosis Extracellular vesicles GBM GSCs Prognosis Therapy |
| Type | Article Review |
| Issue Number | 1 |
| Volume Number | 13 |
Files in this item
This item appears in the following Collection(s)
-
Biomedical Research Center Research [669 items ]
-
Mechanical & Industrial Engineering [1252 items ]